《2018年意大利肝病学会/意大利内科学会/意大利传染病和热带病学会/意大利肾脏病学会专家共识:慢性肾脏病患者HCV感染的管理》摘译
DOI: 10.3969/j.issn.1001-5256.2019.04.011
An excerpt of management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN)
-
摘要:
<正>慢性HCV感染是慢性肝病的主要原因,全球患病率为1%~2%。HCV感染与肝损伤及其相关肝外并发症导致的发病率和病死率增加相关。其中,肾脏受累最为常见,包括蛋白尿、不同类型的肾小球肾炎、冷球蛋白血症(mixed cryoglobulinemia,MC)和慢性肾脏病(chronic kidney disease,CKD)。目前普遍认为HCV感染易发生CKD,且能够增加非透析CKD患者终末期
-
Key words:
- kidney diseases /
- hepacivirus /
- clinical protocols /
- Italy /
- consensus
计量
- 文章访问数: 230
- HTML全文浏览量: 8
- PDF下载量: 104
- 被引次数: 0